Citrate anticoagulation in the ICU: the Leeds experience

Area of Science:

• Nephrology
• Critical Care Medicine
• Pharmacology

Background:

• Continuous renal replacement therapy (CRRT) is essential for critically ill patients with acute kidney injury.
• Effective anticoagulation of the extracorporeal circuit is crucial for CRRT.
• Heparin anticoagulation presents challenges, increasing interest in alternatives like regional citrate anticoagulation.

Purpose of the Study:

• To examine the rationale behind switching from heparin to citrate for CRRT anticoagulation.
• To detail the implementation process of regional citrate anticoagulation in intensive care units (ICUs).
• To assess the impact of this quality improvement project on patient outcomes and ICU nursing staff feedback.

Main Methods:

• A quality improvement project was undertaken at The Leeds Teaching Hospitals NHS Trust.
• The project involved a transition from heparin to regional citrate anticoagulation for CRRT.
• Data on patient outcomes and qualitative feedback from ICU nursing teams were collected and analyzed.

Main Results:

• The study details the reasons for the clinical decision to switch anticoagulation protocols.
• Implementation strategies for regional citrate anticoagulation in the ICU setting are described.
• The impact on patient outcomes and the experiences of the ICU nursing team are presented.

Conclusions:

• Regional citrate anticoagulation offers a viable alternative to heparin for CRRT in ICUs.
• The transition required careful planning and execution as a quality improvement initiative.
• Further analysis of patient data and nursing feedback informs best practices for citrate anticoagulation in CRRT.